 | • レポートコード：QY2203B06980 • 出版社/出版日：QYResearch / 2022年3月18日 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のリゾホスファチジン酸レセプター1の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にリゾホスファチジン酸レセプター1の世界市場のxxx％を占める「Rx-100」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「代謝異常」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のリゾホスファチジン酸レセプター1の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのリゾホスファチジン酸レセプター1市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのリゾホスファチジン酸レセプター1市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 リゾホスファチジン酸レセプター1のグローバル主要メーカーには、Bristol-Myers Squibb Co、Epigen Biosciences Inc、F. Hoffmann-La Roche Ltd、Ono Pharmaceutical Co Ltd、RxBio Inc、Sanofi、Ube Industries Ltdなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 リゾホスファチジン酸レセプター1市場は、種類と用途によって区分されます。世界のリゾホスファチジン酸レセプター1市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 Rx-100、BMS-986020、BMS-986202、SAR-100842、Others 【用途別セグメント】 代謝異常、腫瘍、下痢、腎臓線維症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - リゾホスファチジン酸レセプター1製品概要 - 種類別市場（Rx-100、BMS-986020、BMS-986202、SAR-100842、Others） - 用途別市場（代謝異常、腫瘍、下痢、腎臓線維症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のリゾホスファチジン酸レセプター1販売量予測2017-2028 - 世界のリゾホスファチジン酸レセプター1売上予測2017-2028 - リゾホスファチジン酸レセプター1の地域別販売量 - リゾホスファチジン酸レセプター1の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別リゾホスファチジン酸レセプター1販売量 - 主要メーカー別リゾホスファチジン酸レセプター1売上 - 主要メーカー別リゾホスファチジン酸レセプター1価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（Rx-100、BMS-986020、BMS-986202、SAR-100842、Others） - リゾホスファチジン酸レセプター1の種類別販売量 - リゾホスファチジン酸レセプター1の種類別売上 - リゾホスファチジン酸レセプター1の種類別価格 ・用途別市場規模（代謝異常、腫瘍、下痢、腎臓線維症、その他） - リゾホスファチジン酸レセプター1の用途別販売量 - リゾホスファチジン酸レセプター1の用途別売上 - リゾホスファチジン酸レセプター1の用途別価格 ・北米市場 - 北米のリゾホスファチジン酸レセプター1市場規模（種類別、用途別） - 主要国別のリゾホスファチジン酸レセプター1市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのリゾホスファチジン酸レセプター1市場規模（種類別、用途別） - 主要国別のリゾホスファチジン酸レセプター1市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のリゾホスファチジン酸レセプター1市場規模（種類別、用途別） - 主要国別のリゾホスファチジン酸レセプター1市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のリゾホスファチジン酸レセプター1市場規模（種類別、用途別） - 主要国別のリゾホスファチジン酸レセプター1市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのリゾホスファチジン酸レセプター1市場規模（種類別、用途別） - 主要国別のリゾホスファチジン酸レセプター1市場規模（トルコ、サウジアラビア） ・企業情報 Bristol-Myers Squibb Co、Epigen Biosciences Inc、F. Hoffmann-La Roche Ltd、Ono Pharmaceutical Co Ltd、RxBio Inc、Sanofi、Ube Industries Ltd ・産業チェーン及び販売チャネル分析 - リゾホスファチジン酸レセプター1の産業チェーン分析 - リゾホスファチジン酸レセプター1の原材料 - リゾホスファチジン酸レセプター1の生産プロセス - リゾホスファチジン酸レセプター1の販売及びマーケティング - リゾホスファチジン酸レセプター1の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - リゾホスファチジン酸レセプター1の産業動向 - リゾホスファチジン酸レセプター1のマーケットドライバー - リゾホスファチジン酸レセプター1の課題 - リゾホスファチジン酸レセプター1の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Lysophosphatidic Acid Receptor 1 Market
Due to the COVID-19 pandemic, the global Lysophosphatidic Acid Receptor 1 market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Rx-100 accounting for % of the Lysophosphatidic Acid Receptor 1 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Metabolic Disorders segment is altered to an % CAGR throughout this forecast period.
China Lysophosphatidic Acid Receptor 1 market size is valued at US$ million in 2021, while the US and Europe Lysophosphatidic Acid Receptor 1 are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Lysophosphatidic Acid Receptor 1 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Lysophosphatidic Acid Receptor 1 include Bristol-Myers Squibb Co, Epigen Biosciences Inc, F. Hoffmann-La Roche Ltd, Ono Pharmaceutical Co Ltd, RxBio Inc, Sanofi and Ube Industries Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Lysophosphatidic Acid Receptor 1 Scope and Segment
Lysophosphatidic Acid Receptor 1 market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Lysophosphatidic Acid Receptor 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Rx-100
BMS-986020
BMS-986202
SAR-100842
Others
Segment by Application
Metabolic Disorders
Oncology
Diarrhea
Kidney Fibrosis
Others
By Company
Bristol-Myers Squibb Co
Epigen Biosciences Inc
F. Hoffmann-La Roche Ltd
Ono Pharmaceutical Co Ltd
RxBio Inc
Sanofi
Ube Industries Ltd
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Lysophosphatidic Acid Receptor 1 Product Introduction
1.2 Market by Type
1.2.1 Global Lysophosphatidic Acid Receptor 1 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Rx-100
1.2.3 BMS-986020
1.2.4 BMS-986202
1.2.5 SAR-100842
1.2.6 Others
1.3 Market by Application
1.3.1 Global Lysophosphatidic Acid Receptor 1 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Metabolic Disorders
1.3.3 Oncology
1.3.4 Diarrhea
1.3.5 Kidney Fibrosis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lysophosphatidic Acid Receptor 1 Sales Estimates and Forecasts 2017-2028
2.2 Global Lysophosphatidic Acid Receptor 1 Revenue Estimates and Forecasts 2017-2028
2.3 Global Lysophosphatidic Acid Receptor 1 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Lysophosphatidic Acid Receptor 1 Sales by Region
2.4.1 Global Lysophosphatidic Acid Receptor 1 Sales by Region (2017-2022)
2.4.2 Global Sales Lysophosphatidic Acid Receptor 1 by Region (2023-2028)
2.5 Global Lysophosphatidic Acid Receptor 1 Revenue by Region
2.5.1 Global Lysophosphatidic Acid Receptor 1 Revenue by Region (2017-2022)
2.5.2 Global Lysophosphatidic Acid Receptor 1 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Lysophosphatidic Acid Receptor 1 Sales by Manufacturers
3.1.1 Global Top Lysophosphatidic Acid Receptor 1 Manufacturers by Sales (2017-2022)
3.1.2 Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lysophosphatidic Acid Receptor 1 in 2021
3.2 Global Lysophosphatidic Acid Receptor 1 Revenue by Manufacturers
3.2.1 Global Lysophosphatidic Acid Receptor 1 Revenue by Manufacturers (2017-2022)
3.2.2 Global Lysophosphatidic Acid Receptor 1 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Lysophosphatidic Acid Receptor 1 Revenue in 2021
3.3 Global Lysophosphatidic Acid Receptor 1 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Lysophosphatidic Acid Receptor 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Lysophosphatidic Acid Receptor 1 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lysophosphatidic Acid Receptor 1 Sales by Type
4.1.1 Global Lysophosphatidic Acid Receptor 1 Historical Sales by Type (2017-2022)
4.1.2 Global Lysophosphatidic Acid Receptor 1 Forecasted Sales by Type (2023-2028)
4.1.3 Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Type (2017-2028)
4.2 Global Lysophosphatidic Acid Receptor 1 Revenue by Type
4.2.1 Global Lysophosphatidic Acid Receptor 1 Historical Revenue by Type (2017-2022)
4.2.2 Global Lysophosphatidic Acid Receptor 1 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Lysophosphatidic Acid Receptor 1 Revenue Market Share by Type (2017-2028)
4.3 Global Lysophosphatidic Acid Receptor 1 Price by Type
4.3.1 Global Lysophosphatidic Acid Receptor 1 Price by Type (2017-2022)
4.3.2 Global Lysophosphatidic Acid Receptor 1 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Lysophosphatidic Acid Receptor 1 Sales by Application
5.1.1 Global Lysophosphatidic Acid Receptor 1 Historical Sales by Application (2017-2022)
5.1.2 Global Lysophosphatidic Acid Receptor 1 Forecasted Sales by Application (2023-2028)
5.1.3 Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Application (2017-2028)
5.2 Global Lysophosphatidic Acid Receptor 1 Revenue by Application
5.2.1 Global Lysophosphatidic Acid Receptor 1 Historical Revenue by Application (2017-2022)
5.2.2 Global Lysophosphatidic Acid Receptor 1 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Lysophosphatidic Acid Receptor 1 Revenue Market Share by Application (2017-2028)
5.3 Global Lysophosphatidic Acid Receptor 1 Price by Application
5.3.1 Global Lysophosphatidic Acid Receptor 1 Price by Application (2017-2022)
5.3.2 Global Lysophosphatidic Acid Receptor 1 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Lysophosphatidic Acid Receptor 1 Market Size by Type
6.1.1 North America Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2028)
6.1.2 North America Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2028)
6.2 North America Lysophosphatidic Acid Receptor 1 Market Size by Application
6.2.1 North America Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2028)
6.2.2 North America Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2028)
6.3 North America Lysophosphatidic Acid Receptor 1 Market Size by Country
6.3.1 North America Lysophosphatidic Acid Receptor 1 Sales by Country (2017-2028)
6.3.2 North America Lysophosphatidic Acid Receptor 1 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Lysophosphatidic Acid Receptor 1 Market Size by Type
7.1.1 Europe Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2028)
7.1.2 Europe Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2028)
7.2 Europe Lysophosphatidic Acid Receptor 1 Market Size by Application
7.2.1 Europe Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2028)
7.2.2 Europe Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2028)
7.3 Europe Lysophosphatidic Acid Receptor 1 Market Size by Country
7.3.1 Europe Lysophosphatidic Acid Receptor 1 Sales by Country (2017-2028)
7.3.2 Europe Lysophosphatidic Acid Receptor 1 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Lysophosphatidic Acid Receptor 1 Market Size by Type
8.1.1 Asia Pacific Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2028)
8.1.2 Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2028)
8.2 Asia Pacific Lysophosphatidic Acid Receptor 1 Market Size by Application
8.2.1 Asia Pacific Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2028)
8.2.2 Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2028)
8.3 Asia Pacific Lysophosphatidic Acid Receptor 1 Market Size by Region
8.3.1 Asia Pacific Lysophosphatidic Acid Receptor 1 Sales by Region (2017-2028)
8.3.2 Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Lysophosphatidic Acid Receptor 1 Market Size by Type
9.1.1 Latin America Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2028)
9.1.2 Latin America Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2028)
9.2 Latin America Lysophosphatidic Acid Receptor 1 Market Size by Application
9.2.1 Latin America Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2028)
9.2.2 Latin America Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2028)
9.3 Latin America Lysophosphatidic Acid Receptor 1 Market Size by Country
9.3.1 Latin America Lysophosphatidic Acid Receptor 1 Sales by Country (2017-2028)
9.3.2 Latin America Lysophosphatidic Acid Receptor 1 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Lysophosphatidic Acid Receptor 1 Market Size by Type
10.1.1 Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2028)
10.2 Middle East and Africa Lysophosphatidic Acid Receptor 1 Market Size by Application
10.2.1 Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2028)
10.3 Middle East and Africa Lysophosphatidic Acid Receptor 1 Market Size by Country
10.3.1 Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bristol-Myers Squibb Co
11.1.1 Bristol-Myers Squibb Co Corporation Information
11.1.2 Bristol-Myers Squibb Co Overview
11.1.3 Bristol-Myers Squibb Co Lysophosphatidic Acid Receptor 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bristol-Myers Squibb Co Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bristol-Myers Squibb Co Recent Developments
11.2 Epigen Biosciences Inc
11.2.1 Epigen Biosciences Inc Corporation Information
11.2.2 Epigen Biosciences Inc Overview
11.2.3 Epigen Biosciences Inc Lysophosphatidic Acid Receptor 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Epigen Biosciences Inc Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Epigen Biosciences Inc Recent Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Corporation Information
11.3.2 F. Hoffmann-La Roche Ltd Overview
11.3.3 F. Hoffmann-La Roche Ltd Lysophosphatidic Acid Receptor 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 F. Hoffmann-La Roche Ltd Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 F. Hoffmann-La Roche Ltd Recent Developments
11.4 Ono Pharmaceutical Co Ltd
11.4.1 Ono Pharmaceutical Co Ltd Corporation Information
11.4.2 Ono Pharmaceutical Co Ltd Overview
11.4.3 Ono Pharmaceutical Co Ltd Lysophosphatidic Acid Receptor 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ono Pharmaceutical Co Ltd Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ono Pharmaceutical Co Ltd Recent Developments
11.5 RxBio Inc
11.5.1 RxBio Inc Corporation Information
11.5.2 RxBio Inc Overview
11.5.3 RxBio Inc Lysophosphatidic Acid Receptor 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 RxBio Inc Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 RxBio Inc Recent Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Lysophosphatidic Acid Receptor 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sanofi Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
11.7 Ube Industries Ltd
11.7.1 Ube Industries Ltd Corporation Information
11.7.2 Ube Industries Ltd Overview
11.7.3 Ube Industries Ltd Lysophosphatidic Acid Receptor 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ube Industries Ltd Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ube Industries Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lysophosphatidic Acid Receptor 1 Industry Chain Analysis
12.2 Lysophosphatidic Acid Receptor 1 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lysophosphatidic Acid Receptor 1 Production Mode & Process
12.4 Lysophosphatidic Acid Receptor 1 Sales and Marketing
12.4.1 Lysophosphatidic Acid Receptor 1 Sales Channels
12.4.2 Lysophosphatidic Acid Receptor 1 Distributors
12.5 Lysophosphatidic Acid Receptor 1 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Lysophosphatidic Acid Receptor 1 Industry Trends
13.2 Lysophosphatidic Acid Receptor 1 Market Drivers
13.3 Lysophosphatidic Acid Receptor 1 Market Challenges
13.4 Lysophosphatidic Acid Receptor 1 Market Restraints
14 Key Findings in The Global Lysophosphatidic Acid Receptor 1 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Lysophosphatidic Acid Receptor 1 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Rx-100
Table 3. Major Manufacturers of BMS-986020
Table 4. Major Manufacturers of BMS-986202
Table 5. Major Manufacturers of SAR-100842
Table 6. Major Manufacturers of Others
Table 7. Global Lysophosphatidic Acid Receptor 1 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Lysophosphatidic Acid Receptor 1 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Lysophosphatidic Acid Receptor 1 Sales by Region (2017-2022) & (K Pcs)
Table 10. Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Region (2017-2022)
Table 11. Global Lysophosphatidic Acid Receptor 1 Sales by Region (2023-2028) & (K Pcs)
Table 12. Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Region (2023-2028)
Table 13. Global Lysophosphatidic Acid Receptor 1 Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Lysophosphatidic Acid Receptor 1 Revenue Market Share by Region (2017-2022)
Table 15. Global Lysophosphatidic Acid Receptor 1 Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Lysophosphatidic Acid Receptor 1 Revenue Market Share by Region (2023-2028)
Table 17. Global Lysophosphatidic Acid Receptor 1 Sales by Manufacturers (2017-2022) & (K Pcs)
Table 18. Global Lysophosphatidic Acid Receptor 1 Sales Share by Manufacturers (2017-2022)
Table 19. Global Lysophosphatidic Acid Receptor 1 Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Lysophosphatidic Acid Receptor 1 Revenue Share by Manufacturers (2017-2022)
Table 21. Lysophosphatidic Acid Receptor 1 Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 22. Global Lysophosphatidic Acid Receptor 1 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Lysophosphatidic Acid Receptor 1 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lysophosphatidic Acid Receptor 1 as of 2021)
Table 24. Lysophosphatidic Acid Receptor 1 Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Lysophosphatidic Acid Receptor 1 Product Offered
Table 26. Date of Manufacturers Enter into Lysophosphatidic Acid Receptor 1 Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 29. Global Lysophosphatidic Acid Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 30. Global Lysophosphatidic Acid Receptor 1 Sales Share by Type (2017-2022)
Table 31. Global Lysophosphatidic Acid Receptor 1 Sales Share by Type (2023-2028)
Table 32. Global Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Lysophosphatidic Acid Receptor 1 Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Lysophosphatidic Acid Receptor 1 Revenue Share by Type (2017-2022)
Table 35. Global Lysophosphatidic Acid Receptor 1 Revenue Share by Type (2023-2028)
Table 36. Lysophosphatidic Acid Receptor 1 Price by Type (2017-2022) & (USD/Pcs)
Table 37. Global Lysophosphatidic Acid Receptor 1 Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 38. Global Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 39. Global Lysophosphatidic Acid Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 40. Global Lysophosphatidic Acid Receptor 1 Sales Share by Application (2017-2022)
Table 41. Global Lysophosphatidic Acid Receptor 1 Sales Share by Application (2023-2028)
Table 42. Global Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Lysophosphatidic Acid Receptor 1 Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Lysophosphatidic Acid Receptor 1 Revenue Share by Application (2017-2022)
Table 45. Global Lysophosphatidic Acid Receptor 1 Revenue Share by Application (2023-2028)
Table 46. Lysophosphatidic Acid Receptor 1 Price by Application (2017-2022) & (USD/Pcs)
Table 47. Global Lysophosphatidic Acid Receptor 1 Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 48. North America Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 49. North America Lysophosphatidic Acid Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 50. North America Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Lysophosphatidic Acid Receptor 1 Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 53. North America Lysophosphatidic Acid Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 54. North America Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Lysophosphatidic Acid Receptor 1 Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Lysophosphatidic Acid Receptor 1 Sales by Country (2017-2022) & (K Pcs)
Table 57. North America Lysophosphatidic Acid Receptor 1 Sales by Country (2023-2028) & (K Pcs)
Table 58. North America Lysophosphatidic Acid Receptor 1 Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Lysophosphatidic Acid Receptor 1 Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 61. Europe Lysophosphatidic Acid Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 62. Europe Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Lysophosphatidic Acid Receptor 1 Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 65. Europe Lysophosphatidic Acid Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Lysophosphatidic Acid Receptor 1 Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Lysophosphatidic Acid Receptor 1 Sales by Country (2017-2022) & (K Pcs)
Table 69. Europe Lysophosphatidic Acid Receptor 1 Sales by Country (2023-2028) & (K Pcs)
Table 70. Europe Lysophosphatidic Acid Receptor 1 Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Lysophosphatidic Acid Receptor 1 Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 73. Asia Pacific Lysophosphatidic Acid Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 74. Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 77. Asia Pacific Lysophosphatidic Acid Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 78. Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Lysophosphatidic Acid Receptor 1 Sales by Region (2017-2022) & (K Pcs)
Table 81. Asia Pacific Lysophosphatidic Acid Receptor 1 Sales by Region (2023-2028) & (K Pcs)
Table 82. Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 85. Latin America Lysophosphatidic Acid Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 86. Latin America Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Lysophosphatidic Acid Receptor 1 Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 89. Latin America Lysophosphatidic Acid Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 90. Latin America Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Lysophosphatidic Acid Receptor 1 Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Lysophosphatidic Acid Receptor 1 Sales by Country (2017-2022) & (K Pcs)
Table 93. Latin America Lysophosphatidic Acid Receptor 1 Sales by Country (2023-2028) & (K Pcs)
Table 94. Latin America Lysophosphatidic Acid Receptor 1 Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Lysophosphatidic Acid Receptor 1 Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales by Type (2017-2022) & (K Pcs)
Table 97. Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales by Type (2023-2028) & (K Pcs)
Table 98. Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales by Application (2017-2022) & (K Pcs)
Table 101. Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales by Application (2023-2028) & (K Pcs)
Table 102. Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales by Country (2017-2022) & (K Pcs)
Table 105. Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales by Country (2023-2028) & (K Pcs)
Table 106. Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue by Country (2023-2028) & (US$ Million)
Table 108. Bristol-Myers Squibb Co Corporation Information
Table 109. Bristol-Myers Squibb Co Description and Major Businesses
Table 110. Bristol-Myers Squibb Co Lysophosphatidic Acid Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 111. Bristol-Myers Squibb Co Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Bristol-Myers Squibb Co Recent Developments
Table 113. Epigen Biosciences Inc Corporation Information
Table 114. Epigen Biosciences Inc Description and Major Businesses
Table 115. Epigen Biosciences Inc Lysophosphatidic Acid Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 116. Epigen Biosciences Inc Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Epigen Biosciences Inc Recent Developments
Table 118. F. Hoffmann-La Roche Ltd Corporation Information
Table 119. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 120. F. Hoffmann-La Roche Ltd Lysophosphatidic Acid Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 121. F. Hoffmann-La Roche Ltd Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. F. Hoffmann-La Roche Ltd Recent Developments
Table 123. Ono Pharmaceutical Co Ltd Corporation Information
Table 124. Ono Pharmaceutical Co Ltd Description and Major Businesses
Table 125. Ono Pharmaceutical Co Ltd Lysophosphatidic Acid Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 126. Ono Pharmaceutical Co Ltd Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Ono Pharmaceutical Co Ltd Recent Developments
Table 128. RxBio Inc Corporation Information
Table 129. RxBio Inc Description and Major Businesses
Table 130. RxBio Inc Lysophosphatidic Acid Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 131. RxBio Inc Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. RxBio Inc Recent Developments
Table 133. Sanofi Corporation Information
Table 134. Sanofi Description and Major Businesses
Table 135. Sanofi Lysophosphatidic Acid Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 136. Sanofi Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Sanofi Recent Developments
Table 138. Ube Industries Ltd Corporation Information
Table 139. Ube Industries Ltd Description and Major Businesses
Table 140. Ube Industries Ltd Lysophosphatidic Acid Receptor 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 141. Ube Industries Ltd Lysophosphatidic Acid Receptor 1 Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Ube Industries Ltd Recent Developments
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Lysophosphatidic Acid Receptor 1 Distributors List
Table 146. Lysophosphatidic Acid Receptor 1 Customers List
Table 147. Lysophosphatidic Acid Receptor 1 Market Trends
Table 148. Lysophosphatidic Acid Receptor 1 Market Drivers
Table 149. Lysophosphatidic Acid Receptor 1 Market Challenges
Table 150. Lysophosphatidic Acid Receptor 1 Market Restraints
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Lysophosphatidic Acid Receptor 1 Product Picture
Figure 3. Global Lysophosphatidic Acid Receptor 1 Market Share by Type in 2021 & 2028
Figure 3. Rx-100 Product Picture
Figure 4. BMS-986020 Product Picture
Figure 5. BMS-986202 Product Picture
Figure 6. SAR-100842 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Lysophosphatidic Acid Receptor 1 Market Share by Application in 2021 & 2028
Figure 9. Metabolic Disorders
Figure 10. Oncology
Figure 11. Diarrhea
Figure 12. Kidney Fibrosis
Figure 13. Others
Figure 14. Lysophosphatidic Acid Receptor 1 Report Years Considered
Figure 15. Global Lysophosphatidic Acid Receptor 1 Sales 2017-2028 (K Pcs)
Figure 16. Global Lysophosphatidic Acid Receptor 1 Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Lysophosphatidic Acid Receptor 1 Revenue 2017-2028 (US$ Million)
Figure 18. Global Lysophosphatidic Acid Receptor 1 Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Region (2017-2022)
Figure 20. Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Region (2023-2028)
Figure 21. North America Lysophosphatidic Acid Receptor 1 Sales YoY (2017-2028) & (K Pcs)
Figure 22. North America Lysophosphatidic Acid Receptor 1 Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Lysophosphatidic Acid Receptor 1 Sales YoY (2017-2028) & (K Pcs)
Figure 24. Europe Lysophosphatidic Acid Receptor 1 Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Lysophosphatidic Acid Receptor 1 Sales YoY (2017-2028) & (K Pcs)
Figure 26. Asia-Pacific Lysophosphatidic Acid Receptor 1 Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Lysophosphatidic Acid Receptor 1 Sales YoY (2017-2028) & (K Pcs)
Figure 28. Latin America Lysophosphatidic Acid Receptor 1 Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Lysophosphatidic Acid Receptor 1 Sales YoY (2017-2028) & (K Pcs)
Figure 30. Middle East & Africa Lysophosphatidic Acid Receptor 1 Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Lysophosphatidic Acid Receptor 1 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Lysophosphatidic Acid Receptor 1 in the World: Market Share by Lysophosphatidic Acid Receptor 1 Revenue in 2021
Figure 33. Global Lysophosphatidic Acid Receptor 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Type (2017-2028)
Figure 35. Global Lysophosphatidic Acid Receptor 1 Revenue Market Share by Type (2017-2028)
Figure 36. Global Lysophosphatidic Acid Receptor 1 Sales Market Share by Application (2017-2028)
Figure 37. Global Lysophosphatidic Acid Receptor 1 Revenue Market Share by Application (2017-2028)
Figure 38. North America Lysophosphatidic Acid Receptor 1 Sales Market Share by Type (2017-2028)
Figure 39. North America Lysophosphatidic Acid Receptor 1 Revenue Market Share by Type (2017-2028)
Figure 40. North America Lysophosphatidic Acid Receptor 1 Sales Market Share by Application (2017-2028)
Figure 41. North America Lysophosphatidic Acid Receptor 1 Revenue Market Share by Application (2017-2028)
Figure 42. North America Lysophosphatidic Acid Receptor 1 Sales Share by Country (2017-2028)
Figure 43. North America Lysophosphatidic Acid Receptor 1 Revenue Share by Country (2017-2028)
Figure 44. U.S. Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Lysophosphatidic Acid Receptor 1 Sales Market Share by Type (2017-2028)
Figure 47. Europe Lysophosphatidic Acid Receptor 1 Revenue Market Share by Type (2017-2028)
Figure 48. Europe Lysophosphatidic Acid Receptor 1 Sales Market Share by Application (2017-2028)
Figure 49. Europe Lysophosphatidic Acid Receptor 1 Revenue Market Share by Application (2017-2028)
Figure 50. Europe Lysophosphatidic Acid Receptor 1 Sales Share by Country (2017-2028)
Figure 51. Europe Lysophosphatidic Acid Receptor 1 Revenue Share by Country (2017-2028)
Figure 52. Germany Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 53. France Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Lysophosphatidic Acid Receptor 1 Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Lysophosphatidic Acid Receptor 1 Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Lysophosphatidic Acid Receptor 1 Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Lysophosphatidic Acid Receptor 1 Revenue Share by Region (2017-2028)
Figure 63. China Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 66. India Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Lysophosphatidic Acid Receptor 1 Sales Market Share by Type (2017-2028)
Figure 74. Latin America Lysophosphatidic Acid Receptor 1 Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Lysophosphatidic Acid Receptor 1 Sales Market Share by Application (2017-2028)
Figure 76. Latin America Lysophosphatidic Acid Receptor 1 Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Lysophosphatidic Acid Receptor 1 Sales Share by Country (2017-2028)
Figure 78. Latin America Lysophosphatidic Acid Receptor 1 Revenue Share by Country (2017-2028)
Figure 79. Mexico Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Lysophosphatidic Acid Receptor 1 Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Lysophosphatidic Acid Receptor 1 Revenue Share by Country (2017-2028)
Figure 88. Turkey Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 90. U.A.E Lysophosphatidic Acid Receptor 1 Revenue (2017-2028) & (US$ Million)
Figure 91. Lysophosphatidic Acid Receptor 1 Value Chain
Figure 92. Lysophosphatidic Acid Receptor 1 Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed